Financial Perspectives, Inc Werewolf Therapeutics, Inc. Transaction History
Financial Perspectives, Inc
- $264 Billion
- Q1 2024
A detailed history of Financial Perspectives, Inc transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Financial Perspectives, Inc holds 6,750 shares of HOWL stock, worth $18,495. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,750
Previous 6,750
-0.0%
Holding current value
$18,495
Previous $26.1 Million
67.88%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $80.9M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...